跳至主要内容
临床试验/CTRI/2022/08/044866
CTRI/2022/08/044866已完成未知

An investigator initiated, Single center, double blind, placebo control, randomized, pilot clinical study to evaluate Efficacy and Safety of PVPI-0.45% w/v throat spray administered along with standard care of therapy in patients suffering from tonsilitis and pharyngitis (infections).

Dr Harsh Mittal0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
已完成
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1.Male/Female patients aged between 18-65 years
  • 2.Clinical diagnosis of acute tonsillitis/pharyngitis
  • 3.Willingness to comply with the study schedule and procedures.
  • 4.Subjects willing to give written informed consent prior to screening.

排除标准

  • 1.Subjects not willing to give written informed consent
  • 2.Subjects who is willing to adhere to hot water saline gargle.
  • 3.Known cases of Thyroid dysfunction.
  • 4.Patients undergone thyroidectomy.
  • 5.Immunocompromised patients.
  • 6.Known hypersensitivity to any ingredient of the study drug.
  • 7.Severe sepsis
  • 8.Advanced Tonsilo-Pharyngeal disease/ infection.
  • 9.Pregnancy and Lactation.
  • 10.Subject with any condition which in opinion of the investigator makes him/her unsuitable for exclusion.

研究者

发起方
Dr Harsh Mittal

相似试验